This week, researchers at Bar-Ilan University, the US National Institute on Aging and Tel Aviv University reported in Nature Communications that they had reversed key signatures of aging in the livers of old mice by raising levels of a protein called SIRT6 — long nicknamed the “longevity protein.” The lab of Professor Haim Cohen, who directs Bar-Ilan’s Sagol Healthy Human Longevity Center, framed the finding in a sentence that did most of the rhetorical work: the biological changes we associate with growing older might not, after all, be a one-way street.
That single clause is why the story travelled. For most of human history, aging has been the one appointment nobody misses and nobody reschedules. The promise of reversal — not slowing, not managing, but turning the clock backward — lands somewhere between medicine and mythology. So before the word “immortality” does any more damage, it is worth being precise about what actually happened, because the precise version is the one that matters.
What was reversed, and what wasn’t
The team did not extend the lifespan of a person, or even of a mouse. They intervened in a single organ and watched it behave younger: the architecture of the DNA inside liver cells shifted back toward a more youthful configuration, and the patterns of gene activity followed. This is reversal at the level of a cellular signature, not at the level of a death certificate. The distinction is not pedantry. A marker moving in the right direction is a hypothesis about health; a longer, healthier life is the thing the marker is supposed to predict. The two are related the way a weather forecast is related to rain.
What gives the result weight is conceptual rather than clinical. For decades the field quietly debated whether aging is simply accumulated damage — entropy with a pulse — or whether it is, at least in part, a regulated program the body runs and could, in principle, be persuaded to run differently. Every clean demonstration that a deliberate molecular nudge can push an old tissue back toward a young state tilts the argument toward the second view. SIRT6 sits exactly on that fault line: it is a regulator, an editor of how the genome is packed and read. Turning its dial up and watching age-related decline recede is the kind of evidence that changes how scientists frame the problem, not just how they treat it.
Aging’s real defence was never biology. It was the assumption of inevitability.
Why a mouse liver is the right place to be sceptical
Caution is not cynicism; it is the discipline the subject demands. The liver is the body’s most forgiving organ, famous for regenerating, which makes it the easy case rather than the hard one. Over-producing a single protein is a clean experiment and a messy therapy: the same lever that rejuvenates one system can dysregulate another, and the history of longevity science is a graveyard of interventions that were spectacular in a dish, respectable in a mouse, and silent in a human. The road from “we moved the signature” to “it is safe, durable and works in people” is measured in years and littered with reasonable-sounding shortcuts that didn’t survive contact with a clinical trial.
The honest reading, then, is neither the tabloid one nor the reflexive dismissal. It is this: a credible group has added another brick to the case that aging is editable, in a specific tissue, under controlled conditions. That is genuinely significant and genuinely incremental at the same time — a combination the attention economy is structurally incapable of holding in one hand.
The long view
The interesting question for the decade ahead is not whether we can rewind a single organ. We now have several proofs that we can. It is whether reversibility scales — across tissues, across the whole organism, across the distance between a lab animal bred for uniformity and a human carrying eighty years of idiosyncratic history. The field is maturing from “can we slow it?” to “is it a program we can rewrite, and at what cost?” That is a far more demanding question, and a far more hopeful one. For those who take time seriously, the lesson of this week is not that the clock can be turned back. It is that aging’s oldest defence — the quiet certainty that it is a one-way street — is the part that is genuinely starting to give.
